EXACT SCIENCES CORP (EXAS) Shares Outstanding (2010 - 2025)

Exact Sciences (EXAS) has reported Shares Outstanding (Entity) for 16 consecutive years, with $190.8 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Shares Outstanding (Entity) rose 2.79% year-over-year to $190.8 million; the TTM figure through Dec 2025 stood at $190.8 million (up 2.79% YoY), while the FY2025 annual figure was $190.8 million, up 2.79% from the prior year.
• Shares Outstanding (Entity) climbed to $190.8 million in Q4 2025 per EXAS's latest filing, from $189.5 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $190.8 million in Q4 2025 and bottomed at $171.3 million in Q1 2021.
• Historically, Shares Outstanding (Entity) has averaged $180.8 million across 5 years, with a median of $180.7 million in 2023.
• Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) gained 14.62% — and 2023, when it rose 1.93%.
• Exact Sciences' Shares Outstanding (Entity) stood at $173.7 million in 2021, then gained by 2.45% to $177.9 million in 2022, then climbed by 1.93% to $181.4 million in 2023, then increased by 2.34% to $185.6 million in 2024, then advanced by 2.79% to $190.8 million in 2025.
• Business Quant data shows EXAS's Shares Outstanding (Entity) at $190.8 million in Q4 2025, $189.5 million in Q3 2025, and $189.2 million in Q2 2025.